734492-43-4

Usage

Uses

Used in Pharmaceutical Industry:
3-Isothiazolecarboxylic acid, 4-amino-, methylester (9CI) is used as a chemical intermediate for the synthesis of various drugs. Its unique structure and properties make it a valuable component in the development of new pharmaceuticals with potential therapeutic applications.
Used in Antimicrobial Applications:
Leveraging its antimicrobial properties, 3-Isothiazolecarboxylic acid, 4-amino-, methylester (9CI) is employed as an antimicrobial agent. It can be incorporated into products to inhibit the growth of microorganisms, contributing to the preservation of materials and the prevention of infections.
Used in Antibacterial Applications:
3-Isothiazolecarboxylicacid,4-amino-,methylester(9CI) is also used as an antibacterial agent, helping to combat bacterial infections. Its incorporation into medical products or treatments can aid in the prevention and management of bacterial diseases.
Used in Antifungal Applications:
3-Isothiazolecarboxylic acid, 4-amino-, methylester (9CI) is utilized in antifungal applications, making it a useful component in products designed to prevent and treat fungal infections.
Used in Dye Production:
As a building block in the production of specialized dyes, 3-Isothiazolecarboxylic acid, 4-amino-, methylester (9CI) contributes to the creation of unique colorants for various industries, including textiles, cosmetics, and art materials.
Used in Organic Compounds Synthesis:
This versatile chemical is also used as a building block in the synthesis of other organic compounds, expanding its applications across a wide range of industries that rely on organic chemistry for their products and processes.

Upstream product

• 67-56-1 methanol 
• 462067-90-9 4-aminoisothiazole-3-carboxylic acid 

Downstream Products

• 874288-79-6 4-(2,6-dichloro-benzoylamino)-isothiazole-3-carboxylic acid methyl ester 
• 896723-24-3 4-(2,6-difluoro-benzoylamino)-isothiazole-3-carboxylic acid methyl ester 

Relevant academic research and scientific papers

Chemical Mutagenesis of an Emissive RNA Alphabet

An evolved fluorescent ribonucleoside alphabet comprising isomorphic purine (tzA, tzG) and pyrimidine (tzU, tzC) analogues, all derived from isothiazolo[4,3-d]pyrimidine as a common heterocyclic core, is describ

HETEROCYCLIC COMPOUND

The present invention relates to a compound which can be useful for the treatment or prevention of SPT-related diseases including cancer and congenital diseases associated with sphingolipid accumulation (including Niemann-Pick disease).

SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

The invention provides substituted imidazo[1,2-b]pyridazine compounds, substituted imidazo[1,5-b]pyridazine compounds, related compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat medical disorders, e.g., Gaucher disease, Parkinson's disease, Lewy body disease, dementia, or multiple system atrophy, in a patient. Exemplary substituted imidazo[1,2-b]pyridazine compounds described herein include substituted imidazo[1,2-b]pyridazine-3-carboxamide compounds and variants thereof.

Iminooxazolidine Derivatives and Their Use

The present application relates to novel iminooxazolidine derivatives, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular thromboembolic disorders.

THIAZOLE AND ISOTHIAZOLE DERIVATIVES THAT MODULATE THE ACIVITY OF CDK, GSK AND AURORA KYNASES

The invention provides a compound of the formula (I): or a salt, N-oxide, tautomer or solvate thereof, wherein X is CR5 or N; each of Q1 and Q2 is a carbon atom; Q3 is selected from S and CH; Q4 is se

PHARMACEUTICAL COMPOUNDS

The invention provides a compound for use in the prophylaxis or treatment of a disease state or condition mediated by a cyclin dependent kinase, the compound having the formula (I): (I) and salts, tautomers, N-oxides or solvates thereof; wherein A is a bond, C=O, NRg(C=O) or O(C=O) wherein Rg is hydrogen or C1-4 hydrocarbyl optionally substituted by hydroxy or C1-4 alkoxy; Y is a bond or an alkylene chain of 1, 2 or 3 carbon atoms in length; Q is S or CR2; J is S or CH; provided that one of Q and J is S, and the other of Q and J is not S; when Q is S, there is a double bond between the ring carbon atoms “a” and “b” and a double bond between the ring nitrogen N and J; and when J is S, there is a double bond between Q and the ring carbon atom “a” and a double bond between the ring nitrogen N and the ring carbon atom “b”; and R1 to R4 are as defined in the claims.